New Microscopy Method Achieves Angstrom-Scale Localization Precision with One Laser

TL;DR

• Researchers at MIT and the Broad Institute have developed U-STORM (upconversion-enabled stochastic optical reconstruction microscopy), a super-resolution imaging technique that achieves 0.62 Å localisation precision — three orders of magnitude beyond conventional fluorescence microscopy.
• The key innovation is a new class of ~10 nm upconverting nanoparticles (UCNPs) that blink spontaneously and indefinitely under a single near-infrared laser, without photobleaching, specialised buffers, or complex optical setups.
• The technique resolves individual proteins — specifically, epidermal growth factor receptor (EGFR) dimers and multimers — on cell membranes at single-protein resolution.
• Simultaneous multicolour imaging is achieved with a single excitation source and a single imaging round, something no previous super-resolution technique has managed.
• Published in Nature Nanotechnology on 27 July 2026.

What Happened

For decades, the fundamental limit on optical microscopy has been the diffraction of light. Visible light has a wavelength of roughly 400–700 nanometres. That means conventional light microscopes cannot resolve objects closer together than about 200–300 nm — fine for seeing cells, useless for seeing the proteins inside them.

Super-resolution techniques — STORM, PALM, MINFLUX, DNA-PAINT — have pushed that limit downward, in some cases to the ångström scale (1 Å = 0.1 nm, roughly the diameter of an atom). But each has trade-offs. Some require complex multi-laser setups. Some need specialised imaging buffers that alter the cellular environment. Some can only image one colour at a time. And all are limited by photobleaching: conventional fluorescent dyes burn out within seconds to minutes, capping the number of localisation events per emitter and therefore the achievable precision.

The U-STORM technique, developed by a team led by Chunte Sam Peng at the Broad Institute of MIT and Harvard and published in Nature Nanotechnology, solves several of these problems simultaneously.¹

The core insight is a new class of upconverting nanoparticles — tiny crystals (~10 nm) doped with lanthanide ions (ytterbium as the sensitiser, thulium or erbium as the emitter). When hit with near-infrared laser light, these particles absorb the energy and re-emit it as visible light. Critically, by tuning the ratio of sensitiser to emitter ions, the researchers discovered a regime in which the particles blink — switching spontaneously between bright and dark states — indefinitely, without ever photobleaching.

A single particle can produce more than 88,000 localisation events. Each individual localisation has a precision of about 18 nm — typical for super-resolution microscopy. But because the same particle can be localised thousands of times, the mean position converges toward the true position with extraordinary precision. The effective localisation precision: 0.62 Å. That is six-hundredths of a nanometre. It is smaller than the distance between two atoms in a chemical bond.²

Why This Is Different

The U-STORM technique is not the first to achieve ångström-level precision. MINFLUX, developed by Stefan Hell's group and published in Science in 2024, reached similar resolution by using a doughnut-shaped laser beam to pinpoint fluorophore positions. DNA-PAINT, developed by Ralf Jungmann's group, achieves high precision through transient DNA binding.

What makes U-STORM distinctive is its simplicity — and what that simplicity enables.

One laser, no buffers. Conventional STORM requires multiple lasers for activation and excitation, plus imaging buffers containing oxygen scavengers and reducing agents to control blinking. These buffers can alter the cellular environment and limit live-cell compatibility. U-STORM uses a single 976 nm near-infrared laser. No buffers. No chemical modulation. The blinking is intrinsic to the nanoparticles themselves.³

Simultaneous multicolour imaging. Because different lanthanide emitters produce different colours under the same excitation, U-STORM can image blue (thulium) and red (erbium) probes simultaneously in a single imaging round. Previous techniques required sequential imaging — one colour, then another — which doubles acquisition time and introduces registration errors. The researchers demonstrated this by resolving heterodimers (pairs of differently coloured nanoparticles) that were indistinguishable in electron microscopy.⁴

No photobleaching. The nanoparticles were imaged continuously for 10 hours without degradation. Both photon output and duty cycle remained stable throughout. Conventional fluorophores bleach within minutes. This indefinite stability is what enables the accumulation of tens of thousands of localisations per particle — and therefore the sub-ångström precision.⁵

Small probe size. At ~10 nm, the UCNPs are comparable in size to the antibodies used to target them to specific proteins. Larger nanoparticles (25–176 nm, used in previous approaches) can disrupt the biological structures they are meant to image and cannot access crowded cellular environments. The small size is not a convenience; it is a requirement for biological relevance.⁶

The Mechanism

The researchers did not just build the probes. They figured out why they blink.

The blinking arises from a combination of efficient energy migration within the ytterbium lattice and electron trapping at interfacial defect states between the nanoparticle core and its inert shell. At high Yb³⁺ concentrations (99.5%) and low emitter concentrations (0.5% Tm³⁺), excitation energy funnels efficiently to individual thulium ions. Electrons from excited thulium states can be captured by traps at the core-shell interface, quenching emission (OFF state). When the electron is released, emission resumes (ON state). The stochastic trapping and release drives the blinking.⁷

This mechanistic understanding is not just academically satisfying. It provides a design framework for engineering blinking behaviour in other lanthanide systems — potentially expanding the colour palette beyond blue and red to green, ultraviolet, or infrared.

The Biological Demonstration

The researchers did not stop at proof of concept. They used U-STORM to image a biologically important system: the epidermal growth factor receptor (EGFR), a membrane protein involved in cell growth and a target for cancer therapies.

U2OS cells expressing HaloTag-EGFR were labelled with blue- and red-emitting UCNPs conjugated to HaloTag ligands. After stimulation with epidermal growth factor (EGF), U-STORM resolved EGFR dimers and higher-order multimers at the basal membrane with nanometre precision. The nearest-neighbour distance distribution peaked at 55 nm — consistent with the expected separation of two labelled EGFR molecules based on the known dimer structure.⁸

Unstimulated cells showed only sparse dimer formation. The difference between stimulated and unstimulated conditions was statistically significant and matched simulations of random versus clustered receptor distributions.

This is not the first time EGFR dimers have been imaged. But doing it with a single laser, in a single imaging round, without buffers, at sub-ångström precision, using probes that do not bleach — that is new.

What It Actually Means

U-STORM is not going to replace conventional fluorescence microscopy tomorrow. The technique has real limitations: the nanoparticles are larger than organic dyes, the colour palette is currently limited to two channels, and the acquisition times are long (accumulating 88,000 localisations takes time).

But the significance is not about replacing existing techniques. It is about what becomes possible when the probe itself — rather than the instrument — provides the switching mechanism.

The history of super-resolution microscopy has been a history of increasingly complex instruments. STORM requires multiple lasers and specialised buffers. MINFLUX requires a doughnut-shaped beam and nanometre-precision scanning. DNA-PAINT requires multiple rounds of strand exchange. Each advance in resolution has come with an advance in instrumental complexity — and therefore in cost, expertise required, and barriers to adoption.

U-STORM inverts this logic. The complexity is in the probe, not the microscope. The instrument is a standard wide-field fluorescence microscope with a single near-infrared laser. The nanoparticles do the rest. If the probes can be made widely available — and the Nature Nanotechnology paper includes detailed synthesis protocols — any lab with a fluorescence microscope could, in principle, achieve ångström-level precision.

That is the democratising potential. It is also the commercial potential. The researchers have filed a patent. If the probes can be manufactured at scale and conjugated to a range of targeting ligands (antibodies, nanobodies, aptamers), U-STORM could become a kit-based technique — add the probes to your sample, image with your existing microscope, achieve resolution that previously required a million-dollar instrument.

Stakeholder Landscape

Academic microscopy labs gain a new tool that is simpler and cheaper than existing ångström-resolution techniques. The barrier to entry is probe synthesis, not instrument cost.

The pharmaceutical industry gains a technique for imaging drug targets — receptors, ion channels, signalling complexes — at single-protein resolution in their native cellular environment. EGFR is a cancer target. The same approach could be applied to any membrane protein for which a targeting ligand exists.

The microscopy industry (Zeiss, Leica, Nikon, Olympus) faces an interesting dynamic. U-STORM works on standard wide-field microscopes. If the technique is widely adopted, it could reduce demand for specialised super-resolution instruments — or it could increase demand for microscopes optimised for U-STORM workflows.

The nanoparticle industry gains a new application. Lanthanide-doped UCNPs have been a niche research area for two decades. U-STORM provides a compelling use case that could drive investment in scalable synthesis and commercialisation.

Structural biology gains a complementary technique. Cryo-EM and X-ray crystallography provide static structures. U-STORM provides dynamic information — where proteins are, how they cluster, how clustering changes in response to stimuli — in a cellular context.

Cross-Layer Implications

Instrument democratisation: The most important implication may be economic. Ångström-resolution microscopy currently requires instruments costing hundreds of thousands to millions of dollars. If the complexity can be shifted to the probe, the cost of entry drops by orders of magnitude. This is the same dynamic that made next-generation sequencing accessible: move the complexity from the instrument to the consumable.

Drug discovery: The ability to image drug targets at single-protein resolution in cells — and to see how they cluster, dimerise, and internalise in response to drugs — could accelerate target validation and mechanism-of-action studies. EGFR is just the demonstration case.

Nanophotonics: The mechanistic insight — that blinking arises from energy funneling and interfacial electron trapping — provides a design framework for engineering optical switching in other nanomaterial systems. This has implications beyond microscopy: optical memory, sensing, and quantum information processing all use optically switchable materials.

Biological understanding: The resolution of EGFR multimers — not just dimers, but higher-order clusters — adds to a growing body of evidence that membrane receptor signalling is more spatially organised than previously thought. Techniques that can resolve this organisation at the single-protein level will reshape our understanding of how cells process signals.

What This Means for You

If you are a researcher using super-resolution microscopy: U-STORM is not yet commercially available, but the synthesis protocols are published. Labs with nanoparticle synthesis capability can produce the probes now. The optical setup is a standard wide-field microscope with a 976 nm laser — equipment that many core facilities already have. The analysis pipeline uses SLIMfast2, an open-source MATLAB package.

If you are in drug discovery or target validation: Watch this space. The ability to image receptor clustering at single-protein resolution in cells — without the artefacts introduced by imaging buffers or complex fixation protocols — is directly relevant to understanding how drugs modulate receptor behaviour. The EGFR demonstration is a proof of concept for a technique that could be applied to any membrane protein target.

If you are in the microscopy or life sciences tools industry: The probe-as-instrument paradigm has commercial implications. If U-STORM probes can be manufactured at scale and sold as kits, the addressable market is every lab with a fluorescence microscope — not just the minority with specialised super-resolution instruments.

If you are a general reader: This is a genuine breakthrough in a field — biological imaging — where progress is usually incremental. The combination of sub-ångström precision, single-laser simplicity, indefinite probe stability, and simultaneous multicolour imaging is not an optimisation of existing techniques. It is a new category.

Uncertainty Ledger

• Live-cell compatibility: The current demonstration used fixed cells. The researchers note that live-cell imaging is a goal, but the long acquisition times required to accumulate sufficient localisations may limit applicability to slowly moving or spatially confined targets.
• Colour palette: Two colours (blue and red) is a start. Expanding to green, far-red, or infrared through co-doping strategies or additional lanthanide emitters is theoretically possible but not yet demonstrated.
• Probe size: 10 nm is small for a nanoparticle but large compared to organic dyes (~1 nm). For some applications — imaging densely packed proteins in synapses or nuclear pores — even 10 nm may be too large. Further size reduction is a stated goal.
• Commercialisation timeline: The patent has been filed. Whether the probes can be manufactured at scale, with consistent quality, and conjugated to a range of targeting ligands is the commercialisation question. The history of nanoparticle-based biological probes suggests this is non-trivial.
• Replication: The paper was published on 27 July 2026. Independent replication by other labs has not yet occurred. The synthesis protocols are detailed, which supports replicability, but the proof will be in independent demonstration.

Bottom Line

A team at MIT and the Broad Institute has built a microscope that can see individual proteins at a resolution smaller than the distance between two bonded atoms — using nanoparticles that blink forever, a single laser, and no specialised buffers. The technique is simpler, cheaper, and more versatile than anything that has achieved comparable resolution before. It will not replace existing methods overnight. But it opens a path to ångström-resolution imaging for any lab with a fluorescence microscope — and that democratisation, more than the resolution itself, is what will matter in the long run.